Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
SLAS Discovery : Advancing Life Sciences R & D|January 17, 2025
Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discoveryAbdeldjalil Madani, Nadine Alvarez, Steven Park, et al.
Plos One|September 18, 2020
Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessusAbdeldjalil Madani, Ivy Mallick, Alexandre Guy, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessusDereje Abate Negatu, Andreas Beuchel, Abdeldjalil Madani, et al.
International Journal of Antimicrobial Agents|December 16, 2017
Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseasesPhuong Chi Nguyen, Abdeldjalil Madani, Pierre Santucci, et al.
Antimicrobial Agents and Chemotherapy|August 25, 2022
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessusAbdeldjalil Madani, Dereje A Negatu, Abdellatif El Marrouni, et al.
Scientific Reports|September 20, 2017
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosisPhuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, et al.
ACS Infectious Diseases|July 13, 2019
Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of Mycobacterium abscessusAbdeldjalil Madani, Jeremy N Ridenour, Benjamin P Martin, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
Pageof 1